<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>MYA Space | Burris Worm | Activity</title>
	<link>https://space.mya.co.uk/members/mapleocean9/activity/</link>
	<atom:link href="https://space.mya.co.uk/members/mapleocean9/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Burris Worm.</description>
	<lastBuildDate>Thu, 01 Oct 2026 01:55:18 +0100</lastBuildDate>
	<generator>https://buddypress.org/?v=10.2.0</generator>
	<language>en-GB</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">e06b14d7a93fe22e4c90a7d5300ea827</guid>
				<title>Burris Worm posted an update: Western mark indicated that THSWD input might significantly [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1653161/</link>
				<pubDate>Mon, 16 Oct 2023 08:21:01 +0100</pubDate>

									<content:encoded><![CDATA[<p>Western mark indicated that THSWD input might significantly decrease PTGS2, CASP3, NFKB1, p-CASP3 and p-NFKB1, although enhancing the term associated with TP53 proteins in the STI examples of rats. In line with the connection between UPLC-Q-TOF-MS, community pharmacology as well as trial and error affirmation, substances throughout THSWD might&hellip;<span class="activity-read-more" id="activity-read-more-1653161"><a href="https://space.mya.co.uk/activity/p/1653161/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">c4d3df9c7b4f71fbdcd1f87f9fd6d9c7</guid>
				<title>Burris Worm posted an update: Dual-targeted treatment therapy is the standard adjuvant [&#133;]</title>
				<link>https://space.mya.co.uk/activity/p/1648038/</link>
				<pubDate>Sun, 15 Oct 2023 21:40:26 +0100</pubDate>

									<content:encoded><![CDATA[<p>Dual-targeted treatment therapy is the standard adjuvant strategy to human skin expansion aspect receptor 2-positive (HER2+) along with lymph node-positive (LN+) cancer of the breast. Nonetheless, the optimal therapeutic way of people with HER2+ and also lymph node-negative (LN-) breast cancer remains cloudy. This population-based review aimed&hellip;<span class="activity-read-more" id="activity-read-more-1648038"><a href="https://space.mya.co.uk/activity/p/1648038/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">e83feb676e51fcdcce60930e14b80c7b</guid>
				<title>Burris Worm became a registered member</title>
				<link>https://space.mya.co.uk/activity/p/1647805/</link>
				<pubDate>Sun, 15 Oct 2023 21:21:02 +0100</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>
<!--
Performance optimized by W3 Total Cache. Learn more: https://www.boldgrid.com/w3-total-cache/

Object Caching 0/128 objects using Redis
Page Caching using Disk: Enhanced 
Lazy Loading
Database Caching using Redis (Request-wide modification query)

Served from: space.mya.co.uk @ 2026-10-01 07:33:44 by W3 Total Cache
-->